SCC to revisit “method of medical treatment” patent claims
By EsqSocial Corporation 24/03/25
This spring, the Supreme Court of Canada (SCC) will consider the scope of patentable subject-matter as it relates to “methods of medical treatment”. In the underlying action, Janssen asserted that Pharmascience would infringe its Canadian Patent No. 2,655,335 (335 Patent) relating to paliperidone palmitate (INVEGA SUSTENNA) with its generic version....
By: Smart & Biggar